Lympho Bob

A blog about Cancer in general, and Follicular Lymphoma in particular

Sunday, July 30, 2023

Heart Problems and CAR-T/Bispecifics

›
 MedPage Today has a really interesting piece this week, looking at a review article published in JCO Oncology Practice . The review articl...
Monday, July 24, 2023

New Bispecific for FL: TNB-486

›
I don't usually report much on the European Hematology Association Congress , the annual meeting for blood cancer specialists in Europe....
1 comment:
Thursday, July 20, 2023

Zanubrutinib Plus Obinutuzumab for FL?

›
The FDA has accepted a supplemental Biologics License for the combination of Zanubrutinib and Obinutuzumab for patients with Relapsed/Refra...
Friday, July 14, 2023

Artificial Intelligence and Cancer

›
 I just saw a really thought-provoking article fro ASCO Daily News called " AI in Cancer Research and Care: Setting the Stage for a Pro...
3 comments:
Monday, July 10, 2023

FLF Webinar

›
As I said last post, I'm still going through some posts that I had saved up for a while. This one is a video from the Follicular Lymphom...
Wednesday, July 5, 2023

Unsuccessful Trial: Ibrutinib + Chemo

›
I'm finished looking at ASCO presentations, so let's move on to all of the stuff I haven't been able to look at from the last mo...
Friday, June 30, 2023

ASCO Follow-Ups

›
Very quick post. I wanted to share a couple of follow-up or analysis pieces from ASCO. About this time (maybe 3 weeks after ASCO is over), w...
‹
›
Home
View web version

Contributors

  • Lymphomaniac
  • Lymphomaniac
Powered by Blogger.